Literature DB >> 28934402

A World Health Organization field trial assessing a proposed ICD-11 framework for classifying patient safety events.

Alan J Forster1,2,3, Burnand Bernard4, Saskia E Drösler5, Yana Gurevich6, James Harrison7, Jean-Marie Januel8, Patrick S Romano9, Danielle A Southern10, Vijaya Sundararajan11,12, Hude Quan10, Saskia E Vanderloo2, Harold A Pincus13,14,15, William A Ghali10.   

Abstract

OBJECTIVE: To assess the utility of the proposed World Health Organization (WHO)'s International Classification of Disease (ICD) framework for classifying patient safety events.
SETTING: Independent classification of 45 clinical vignettes using a web-based platform. STUDY PARTICIPANTS: The WHO's multi-disciplinary Quality and Safety Topic Advisory Group. MAIN OUTCOME MEASURE(S): The framework consists of three concepts: harm, cause and mode. We defined a concept as 'classifiable' if more than half of the raters could assign an ICD-11 code for the case. We evaluated reasons why cases were nonclassifiable using a qualitative approach.
RESULTS: Harm was classifiable in 31 of 45 cases (69%). Of these, only 20 could be classified according to cause and mode. Classifiable cases were those in which a clear cause and effect relationship existed (e.g. medication administration error). Nonclassifiable cases were those without clear causal attribution (e.g. pressure ulcer). Of the 14 cases in which harm was not evident (31%), only 5 could be classified according to cause and mode and represented potential adverse events. Overall, nine cases (20%) were nonclassifiable using the three-part patient safety framework and contained significant ambiguity in the relationship between healthcare outcome and putative cause.
CONCLUSIONS: The proposed framework enabled classification of the majority of patient safety events. Cases in which potentially harmful events did not cause harm were not classifiable; additional code categories within the ICD-11 are one proposal to address this concern. Cases with ambiguity in cause and effect relationship between healthcare processes and outcomes remain difficult to classify.
© The Author 2017. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  International Classification of Diseases; World Health Organization; patient safety; quality indicators

Mesh:

Year:  2017        PMID: 28934402     DOI: 10.1093/intqhc/mzx070

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  5 in total

1.  A comparison of two structured taxonomic strategies in capturing adverse events in U.S. hospitals.

Authors:  John M Austin; Erin M Kirley; Michael A Rosen; Bradford D Winters
Journal:  Health Serv Res       Date:  2018-11-25       Impact factor: 3.402

2.  MAPPING ICD-11 (THE 11TH INTERNATIONAL CLASSIFICATION OF DISEASE) TO ICD-10-KM-7TH (THE KOREAN MODIFICATION 7TH OF THE ICD-10) FOR FLEXIBLE TRANSITION TO ICD-11.

Authors:  Hyunkyung Lee
Journal:  Perspect Health Inf Manag       Date:  2021-07-01

3.  Decision algorithm for when to use the ICD-11 3-part model for healthcare harms.

Authors:  Cathy A Eastwood; Shahreen Khair; Danielle A Southern
Journal:  BMC Med Inform Decis Mak       Date:  2022-06-07       Impact factor: 3.298

Review 4.  The three-part model for coding causes and mechanisms of healthcare-related adverse events.

Authors:  Danielle A Southern; James E Harrison; Patrick S Romano; Marie-Annick Le Pogam; Harold A Pincus; William A Ghali
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-24       Impact factor: 2.796

5.  A comparison of outcomes between Canada and the United States in patients recovering from hip fracture repair: secondary analysis of the FOCUS trial.

Authors:  Lauren A Beaupre; Eugene K Wai; Donald R Hoover; Helaine Noveck; Darren M Roffey; Donald R Cook; Jay S Magaziner; Jeffrey L Carson
Journal:  Int J Qual Health Care       Date:  2018-03-01       Impact factor: 2.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.